Recently, studies performed with deep sequencing technologies, either whole exome sequencing (WES) [10] or targeted sequencing [11–13], have shown that, with a few exceptions, RET is the only oncogene altered in MTC. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.